You are here

  • Home
  • Archive
  • Volume 7, Issue 7
  • Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial

Article metrics

Article menu

Download PDFPDF

XML
Neurology
Research
Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 2018848415
Feb 201856563
Mar 2018971009
Apr 201847478
May 2018525212
Jun 201853536
Jul 2018515115
Aug 2018707017
Sep 2018565614
Oct 201861617
Nov 20181121129
Dec 201811511514
Jan 201911311324
Feb 2019939323
Mar 201914414122
Apr 201914714616
May 201916116112
Jun 201919719519
Jul 201917617521
Aug 201917117119
Oct 201920120025
Nov 201917117120
Dec 201917317321
Jan 202017517224
Feb 202017317311
Mar 202016216216
May 202013513515
Jun 202011411420
Jul 202016416117
Aug 202012412222
Sep 202019719214
Oct 202023223114
Nov 202024524520
Dec 202026125533
Jan 202122322137
Feb 202120319714
Mar 202125525033
Apr 202129229330
May 202135836533
Jun 202137538423
Jul 202144946424
Aug 202133033125
Sep 202134835722
Oct 202137438240
Nov 202112713128
Dec 202139641337
Jan 202249953041
Feb 202235237558
Mar 202230631335
Apr 202233734027
May 202234134633
Jun 202227929029
Jul 202223324017
Aug 202222222614
Sep 202221821429
Oct 202222723517
Nov 202218718826
Dec 202212213114
Jan 20231311357
Feb 202312513015
Mar 202314714924
Apr 202310710825
May 20239810030
Jun 202312112713
Jul 202312613533
Aug 202315215512
Sep 202311111112
Oct 202313714028
Nov 202313914115
Dec 2023909423
Jan 2024444513
Feb 2024989826
Mar 202414614282
Apr 2024586118
Total13466136451619